Enclomiphene Market Growth Driven by Rising Awareness of Male Infertility Treatments
Market Overview The global Enclomiphene Market is experiencing notable growth, driven by increasing awareness regarding male reproductive health, rising prevalence of hypogonadism, and growing demand for non-testosterone replacement therapies. Enclomiphene, a selective estrogen receptor modulator (SERM), has emerged as a promising treatment option for men suffering from secondary hypogonadism and infertility. Its ability to stimulate endogenous testosterone production while preserving fertility has positioned it as an attractive alternative to conventional testosterone replacement therapies. The global enclomiphene market is estimated at approximately USD 213.9 million in 2025, with steady growth expected during the 2026–2034 period. Market expansion is primarily driven by rising diagnosis of male hypogonadism, increasing demand for fertility-preserving testosterone restoration therapies, and growing adoption of telehealth-based men’s health services. The market is pr...